Evidence map›Paper›PMID 38440982›Full record

ArticleJournal of virology2024

FeLIX is a restriction factor for mammalian retrovirus infection.

Didik Pramono, Dai Takeuchi, Masato Katsuki, Loai AbuEed, Dimas Abdillah, Tohru Kimura, Junna Kawasaki, Ariko Miyake, Kazuo Nishigaki

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Didik PramonoLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Dai TakeuchiLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Masato KatsukiLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Loai AbuEedLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Dimas AbdillahLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Tohru KimuraThe Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Junna KawasakiFaculty of Science and Engineering, Waseda University, Tokyo, Japan.ORCID 0000-0002-6609-5300
Ariko MiyakeLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.
Kazuo NishigakiLaboratory of Molecular Immunology and Infectious Disease, The Joint Graduate School of Veterinary Medicine, Yamaguchi University, Yamaguchi, Japan.ORCID 0000-0002-7690-2137
Yamaguchi University · JPWaseda University · JP

Funding

KAKENHI 20H03152, 23H02393
6 · The paper itself

Abstract

Endogenous retroviruses (ERVs) are remnants of ancestral viral infections. Feline leukemia virus (FeLV) is an exogenous and endogenous retrovirus in domestic cats. It is classified into several subgroups (A, B, C, D, E, and T) based on viral receptor interference properties or receptor usage. ERV-derived molecules benefit animals, conferring resistance to infectious diseases. However, the soluble protein encoded by the defective envelope (

Indexed as

Gene Products, envLeukemia, FelineLeukemia Virus, FelineAnimalsCatsEndogenous RetrovirusesFemaleLeukemia Virus, Gibbon ApePhosphate Transport ProteinsReceptors, VirusRetroviridae InfectionsSolubilityGene Products, envPhosphate Transport ProteinsReceptors, Virusendogenous retrovirusfeline leukemia virusrestriction factor

Identifiers

PMID38440982
PMCPMC11019853
OpenAlexW4392472735

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.